Non-invasive vents decrease mortality, hospitalization, ER visits, Viemed study shows
By HME News Staff
Updated 1:17 PM CST, Mon January 11, 2021
.jpg)
LAFAYETTE, La. – Viemed Healthcare has published a study that shows non-invasive ventilation at home improves survival and decreases health care utilization in Medicare beneficiaries with COPD with chronic respiratory failure.
“This study is the first of its kind published in the U.S. and represents a significant milestone in our mission of educating the medical community on the benefits of NIVH,” said Casey Hoyt, Viemed CEO. “The data supports that NIVH is the best-in-class treatment for chronic respiratory failure consequent to COPD. We are excited to share the results of this study with not only our physician referral sources but also with our colleagues and payers throughout the industry.”
The study, which has been published online and in print by the peer-reviewed journal Respiratory Medicine, evaluated clinical outcomes in COPD patients with COPD-CRF treated with NIV at home compared to similar patients who did not receive NIV at home.
Highlights from the study include: The group treated with NIV at home had: a 50% decrease in all-cause mortality during the study period; a 28% decline in the risk of hospitalization; and a 52% reduction in the risk of an emergency room visit.
All data for the study, which was led by Dr. William Frazier, Viemed’s chief medical officer, in conjunction with Precision Health Economics, a bio-statistical and analytics firm, was obtained from the Medicare Limited Data Set and included patients who were diagnosed with COPD and CRF between 2012 and 2018.
Comments